Phase Ib study of tepotinib in EGFR-mutant/c-Met-positive NSCLC: Final data and long-term responders.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Guangdong General Hospital, Guangdong Academy of Medical Sciences, National University Cancer Institute, Singapore, National University Health System, Cancer Science Institute of Singapore, Seoul National University Hospital, National Taiwan University Hospital, Merck KGaA, Darmstadt (Germany), Samsung Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2890379622